Background Alzheimer disease (AD) progression can be monitored by tracking intensity changes in PET standardized uptake value (SUV) ratios of amyloid, tau, and neurodegeneration. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.